if so what companies should I be looking at?
2007-07-13 06:57:24 · 8 answers · asked by Anonymous in Business & Finance ➔ Investing
I have. I like SGMO right now.
I would be very careful. The risk/reward ratio is not in your favor as most biotechs are unprofitable and live and die by trial results and FDA decisions.
We have a member who has formed a group that analyzes biotech filings for the likelihood of getting an FDA approval and posts their conclusions periodically. Their goal is to get into a stock days before the decision to capture the gap up if they think the decision is likely to be positive.
2007-07-13 16:28:09 · answer #1 · answered by Anonymous · 0⤊ 0⤋
Green Would be a better bet. The movement to make everything more green is an industry that will not stop growing for some time. As the whole global warming issue gets bigger there will be bigger push for green products. There are some Biotech firms who are focused on green innovations, so that might be a nice blend for you. But at the same time in the agriculture industry there is a movement in america to pull away from biotech food products and return to more organic products.
To ask to invest in a industry is pretty broad, and as a science I think BioTech will grow, since it is working towards solving major issues, but at the same time I think there will be many failing biotech companies, while over the next 20 years companies offering green solutions will begin to take off.
just one mans opinion
2007-07-13 07:11:48 · answer #2 · answered by Nitch 2 · 0⤊ 0⤋
I have invested in biotech, both stocks and options. It can be very risky, especially the smaller companies that may have only one product in the pipeline. If it gets turned down in FDA trials, the stock can quickly deflate to nothing. I would stick with the big, diversified companies like Genentech (DNA), Amgen (AMGN) and Bristol-Myers Squibb (BMY),
2007-07-13 07:46:07 · answer #3 · answered by Califrich 6 · 0⤊ 0⤋
I have. I'm actually in two right now, EXEL and NSTK. There's a small bull market in biotech right now. I don't think it will last long, though. You want to pick one with a lot of drugs in their pipeline (like the two above) and then you just wait for an FDA approval and sell into the strength.
2007-07-13 19:39:32 · answer #4 · answered by phildarthebuildar 3 · 0⤊ 0⤋
Not particularly, but I have been following this one real closely:
SIRT - Sirtrix
Sirtris Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs for the treatment of diseases associated with aging, including metabolic diseases, such as type 2 diabetes. Its drug candidates are used to mimic beneficial health effects of calorie restriction by activating SIRT1, which is a member of sirtuins enzymes. The company is developing SRT501, a proprietary formulation of resveratrol; proprietary new chemical entities, which are the new activators of SIRT1; and small molecule modulators of other sirtuins and related pathways for drug development in various areas, including metabolic, cardiovascular, and neurological diseases, as well as cancer. Sirtris Pharmaceuticals, Inc. was founded in 2004 and is based in Cambridge, Massachusetts.
2007-07-13 07:11:17 · answer #5 · answered by Menehune 7 · 0⤊ 0⤋
Some of my very worse investments have been in biotech. I think I have learned my lesson.
2007-07-13 08:53:16 · answer #6 · answered by Anonymous · 0⤊ 0⤋
No I wouldn't as I don't think there's much potential in that industry.
2007-07-13 07:13:23 · answer #7 · answered by Anonymous · 0⤊ 0⤋
yes, moderate to strong buy
2007-07-13 09:50:11 · answer #8 · answered by gs_analyst 3 · 0⤊ 0⤋